» Articles » PMID: 23295917

Functional Characterization of Eight Human CYP1A2 Variants: the Role of Cytochrome B5

Overview
Specialties Genetics
Pharmacology
Date 2013 Jan 9
PMID 23295917
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interindividual variability in cytochrome P450 (CYP)-mediated xenobiotic metabolism is extensive. CYP metabolism requires two electrons, which can be donated by NADPH cytochrome P450 oxidoreductase (CYPOR) and/or cytochrome b5 (b5). Although substantial number of studies have reported on the function and effect of b5 in CYP-mediated catalysis, its mode of action is still not fully understood.

Objective: The aim of this work was to examine the effect of b5 on the activities of eight natural-occurring variants of human CYP1A2, namely, T83M, S212C, S298R, G299S, I314V, I386F, C406Y, and R456H.

Materials And Methods: An approach, as used in our former study was applied, coexpressing these polymorphic CYP1A2 variants separately with CYPOR and b5 in the bacterial cell model BTC-CYP. For each variant, 16 different activity parameters were measured, using eight different substrates. This heterogeneous data set was merged with the one of our former study (i.e. without b5) and a multivariate analysis was carried out.

Results: This analysis indicated that b5 seems to have the ability to affect CYP1A2 variants to behave more like the wild-type variant. This was especially the case for variant I386F, for which the presence of b5 was crucial to show activity. Variants T83M and C406Y showed considerably different activity-profiles when in the presence of b5. Furthermore, our data seem to implicate CYP1A2 residue G299 in its interaction with CYPOR and/or b5.

Conclusion: Results indicate the ability of b5 to affect CYP1A2 variants to behave more like the wild-type variant, attenuating detrimental effects of structural mutations of these variants, seemingly through extensive allosteric effects.

Citing Articles

Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity.

Barata I, Rueff J, Kranendonk M, Esteves F J Xenobiot. 2024; 14(2):575-603.

PMID: 38804287 PMC: 11130977. DOI: 10.3390/jox14020034.


Single Mutations in Cytochrome P450 Oxidoreductase Can Alter the Specificity of Human Cytochrome P450 1A2-Mediated Caffeine Metabolism.

Esteves F, Almeida C, Silva S, Saldanha I, Urban P, Rueff J Biomolecules. 2023; 13(7).

PMID: 37509119 PMC: 10377444. DOI: 10.3390/biom13071083.


"" Xenobiotic Metabolism: Advances in Understanding Xenobiotic Metabolism.

van Vugt-Lussenburg B, Capinha L, Reinen J, Rooseboom M, Kranendonk M, Onderwater R Chem Res Toxicol. 2022; 35(7):1184-1201.

PMID: 35768066 PMC: 9297329. DOI: 10.1021/acs.chemrestox.2c00067.


Functional Characterization of 21 Rare Allelic Variants Identified in a Population of 4773 Japanese Individuals by Assessing Phenacetin -Deethylation.

Kumondai M, Rico E, Hishinuma E, Nakanishi Y, Yamazaki S, Ueda A J Pers Med. 2021; 11(8).

PMID: 34442334 PMC: 8401128. DOI: 10.3390/jpm11080690.


The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.

Esteves F, Rueff J, Kranendonk M J Xenobiot. 2021; 11(3):94-114.

PMID: 34206277 PMC: 8293344. DOI: 10.3390/jox11030007.